Monday, November 18, 2024
HomeTagsSPN-830

SPN-830

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

Supernus Pharmaceuticals, Inc. a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced it has...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics